Clinical facts on GLP-1 retinal damage
Access peer-reviewed research, legal updates, and patient guides regarding semaglutide-induced vision loss and NAION.
The semaglutide-NAION link
Key medical publications detailing the statistical correlation between GLP-1 receptor agonists and ischemic optic neuropathy.
Association with NAION
Neuro-Ophthalmology
Symptom Management
A landmark cohort study analyzing the risk of non-arteritic anterior ischemic optic neuropathy in patients prescribed semaglutide.
How to identify early retinal microvascular changes and locate specialized clinical care for sudden vision loss.
Practical guidance for navigating daily tasks, accessing adaptive reading aids, and preserving remaining visual fields.
Active multi-district filings
Preservation of evidence
Consolidated actions
Patients must secure original prescription records, clinical notes, and pharmacy receipts to establish the exact medication timeline.
Federal courts are consolidating individual injury claims into coordinated proceedings to streamline discovery and expert testimony.